Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.

Watt CL, Lelievre R, Parsons GCS, Vergette C, Chirip V, Polskaia N, Lapenskie J, Lo B, Campbell P, Bankapur A, Palidwor G, Downar J.

Open source

DOI
10.3390/curroncol33060363
Published
2026-06-17
Container
Curr Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33060363,
  title = {Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.},
  author = {Watt CL and  Lelievre R and  Parsons GCS and  Vergette C and  Chirip V and  Polskaia N and  Lapenskie J and  Lo B and  Campbell P and  Bankapur A and  Palidwor G and  Downar J.},
  year = {2026},
  journal = {Curr Oncol},
  doi = {10.3390/curroncol33060363},
  url = {https://doi.org/10.3390/curroncol33060363}
}

RIS

TY  - JOUR
TI  - Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.
AU  - Watt CL
AU  -  Lelievre R
AU  -  Parsons GCS
AU  -  Vergette C
AU  -  Chirip V
AU  -  Polskaia N
AU  -  Lapenskie J
AU  -  Lo B
AU  -  Campbell P
AU  -  Bankapur A
AU  -  Palidwor G
AU  -  Downar J.
PY  - 2026
JO  - Curr Oncol
DO  - 10.3390/curroncol33060363
UR  - https://doi.org/10.3390/curroncol33060363
ER  - 

APA

CL, W., R, L., GCS, P., C, V., V, C., N, P., J, L., B, L., P, C., A, B., G, P., & J., D. (2026). Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.. Curr Oncol. https://doi.org/10.3390/curroncol33060363

Source records